AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial in chronic lymphocytic leukaemia (CLL), a study that chief executive Pascal Soriot recently said could be a "blockbuster ...
Learn everything you need to know about Amplify CWP Enhanced Dividend Income ETF (DIVO) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see ...
Advice, rankings and one great story every day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback